"There really wasn't a difference in in surgical outcomes. The patients tolerated it very well,” says Joshua J. Meeks, MD, PhD. “From a urology perspective, I don't think we're going to see any ...

Ian Metzler, MD, discusses developments in imaging and treating stones. Technology for kidney stone surgery is rapidly evolving. In a recent interview with Urology Times®, Ian Metzler, MD, MTM, ...

The C allele of SNP-765G>C in the PTGS2 gene is associated with increased BPH risk in Lebanese men. The study suggests a potential link between the C allele and prostate cancer, supporting findings in ...

SCONE therapy significantly improved neurogenic bladder symptoms, with over 50% of patients achieving a clinically significant response in the CONTINENCE trial. The therapy also showed additional ...

The app-based intervention led to a significant 8-point reduction in IPSS, indicating substantial improvement in LUTS. The app includes physiotherapy, lifestyle modifications, and educational modules, ...

“Given the rates in epidemiologic studies and surveys showing that up to 70% of women are symptomatic, we were surprised to find that only 9% [filled] a prescription,” says Ekene Enemchukwu, MD, MPH, ...

The SECuRE trial is assessing 67Cu-SAR-bisPSMA in mCRPC, focusing on pre-chemotherapy settings and combination therapy with enzalutamide. Interim data shows significant PSA reductions and disease ...

ImmunityBio seeks FDA approval for Anktiva plus BCG in BCG-unresponsive NMIBC papillary indication, supported by QUILT-3.032 trial data. The QUILT-3.032 trial showed a 55.4% disease-free survival at ...

The PRECISION study investigates a 3-fraction SBRT regimen for localized prostate cancer, aiming to reduce side effects compared to the 5-fraction regimen. The study will enroll 100 patients, using ...

Sima P. Porten, MD, MPH, discusses the need to better understand how genetic makeup influences how individuals process environmental toxins. Firefighters face an increased risk of bladder cancer ...

Recent advancements in kidney stone management include novel access sheaths and miniaturized scopes, enhancing treatment options for patients. AI integration in kidney stone management offers ...

“I think it will help patients decide what prostate surgery they want,” says Naeem Bhojani, MD, FRCSC. Three-month data from the WATER III trial (NCT04801381) were recently shared during the 40th ...